Bioequivalence (BE) Study Comparing Fluconazole 150mg Capsule Manufactured in China and in France

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 3, 2019

Primary Completion Date

July 20, 2019

Study Completion Date

July 20, 2019

Conditions

Bioequivalence

Interventions

DRUG

Fluconazole 150mg Capsule Originator

150mg fluconazole capsule (originator) manufactured at Pfizer Fareva, Amboise, France

DRUG

Fluconazole 150mg Capsule Localized Originator

150mg Fluconazole capsule (localized originator) manufactured at Pfizer, Dalian, China

Trial Locations (1)

Wuxi People's Hospital//Phase One Unit, Wuxi